Physicians are frequently called upon to assist fellow passengers who are ill during flight. A recent article addresses the ethical and legal considerations for physicians who provide medical services to patients during commercial flights.
Narrow-spectrum antibiotics, which are recommended as first-line therapy for children hospitalized with community-acquired pneumonia (CAP), show similar outcomes compared with broad-spectrum antibiotics.
For patients with chronic obstructive pulmonary disease (COPD) hospitalized for a respiratory-related event, administration of azithromycin is associated with a prolonged time to next respiratory hospitalization.
Unilateral leg pain and inability to bear weight combined with fever and decreased urinary output were the first signs of a life-threatening infection in a toddler.
The MoxDuo combination of morphine and oxycodone may have a superior respiratory safety profile to that of equianalgesic morphine equivalent doses (MED) of either morphine or oxycodone alone, according to results presented at the American Pain Society's 30th Annual Scientific Meeting.
The Food and Drug Administration has approved the supplemental New Drug Application (sNDA) for Mycamine (micafungin for injection; Astellas Pharma) for the treatment of candidemia, acute disseminated candidiasis, Candida peritonitis and abscesses without meningoencephalitis and/or ocular dissemination in pediatric patients aged <4 months.
The FDA has approved the supplemental new drug applicationfor Orfadin (nitisinone capsules; Sobi) which allows for an extension of shelf life for the 20mg capsules from 24 months to 36 months.
The FDA has approved a supplemental new drug application (sNDA) for Delzicol (mesalamine) Delayed-Release Capsules for the treatment of mildly to moderately active ulcerative colitis in patients ≥5 years of age.
